Business

Roche pays $220m for Westborough company

Swiss diagnostics and drug company Roche bought the Westborough blood testing company Constitution Medical Investors for $220 million on Tuesday.

Roche, which calls itself the world’s largest biotech company, will utilize Constitution Medical Investors’ Bloodhound, a blood testing technology that is designed to provide fast and accurate diagnosis of blood-related diseases. Bloodhound, a device currently in development and not yet approved by the Food and Drug Administration, is the core technology of an automated system that has the capacity to increase laboratory efficiency and to save space.

Advertisement

CMI is a health care investment firm that focuses on early-stage technology funding, specifically with medical devices and testing that diagnoses disease and infection.

In addition to the $220 million paid upfront, the deal also includes the possibility of more payments, depending on whether or not the company reaches “certain milestones,” according to the agreement.

Gail Waterhouse

Gail Waterhouse can be reached at gail.waterhouse@globe.com. Follow her on Twitter at @gailwaterhouse.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com